New-Onset Type 1 Diabetes in Adults

A Phase III, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Clinical Efficacy and Safety of DiaPep277® in Newly Diagnosed Type 1 Diabetes Subjects

IRB Protocol Number

10-1406

All Other Trials

• Diabetes
• Drugs (Pharmacology)

Contact

Elizabeth Cohlmia at 303-724-3974
or elizabeth.cohlmia@ucdenver.edu

Eligibility and Other Participant Information

For more information, please view the study's poster.